NCT01056809

Brief Summary

For patients with primarily generalized colorectal cancer two treatment strategies are compared to establish which strategy gives best overall survival. The traditional strategy is to first resect the primary colorectal tumour and then treat the metastases with chemotherapy followed if possible by surgery. The alternative strategy is to first treat the metastases with chemotherapy followed if possible by surgery and only resect the primary colorectal tumour if there is hope for cure or if symptoms develop that necessitates treatment.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable colorectal-cancer

Timeline
Completed

Started Jan 2010

Geographic Reach
1 country

10 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

January 25, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 26, 2010

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
Last Updated

May 31, 2012

Status Verified

May 1, 2012

Enrollment Period

2.3 years

First QC Date

January 25, 2010

Last Update Submit

May 30, 2012

Conditions

Keywords

Colorectal cancerMetastasesTreatment strategiesColorectal cancer with synchronous metastases

Outcome Measures

Primary Outcomes (1)

  • Overall survival

    3 years after completion of study

Secondary Outcomes (5)

  • 3 year survival for patients treated with curative intent

    3 years after randomization

  • Palliative patients not receiving chemotherapy treated with the traditional strategy

    Completion of study

  • Quality of life

    Every 6 months up to 3 years

  • Health care consumption

    Completion of study

  • Complications and side effects

    Completion of study

Study Arms (2)

Traditional strategy

ACTIVE COMPARATOR

First resection of the primary colorectal tumour, then treatment of metastases with chemotherapy and if possible surgery.

Procedure: Chemotherapy and surgery

Alternative strategy

ACTIVE COMPARATOR

First treatment of metastases with chemotherapy and if possible surgery, later resection of primary colorectal tumour if hope for cure or if symptoms develope that necessitates treatment

Procedure: Chemotherapy and surgery

Interventions

Treatment not specified but in accordance with national guidelines

Alternative strategyTraditional strategy

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with primarily generalized colorectal cancer diagnosed by pathology or typical appearance on x-ray or at endoscopy and where there is uncertainty regarding best treatment strategy

You may not qualify if:

  • Patients not willing to participate or unable to sign informed consent.
  • Patients with other malignancy with metastatic potential
  • Patients where synchronous resection of primary tumour and metastases is planned
  • Patients not fit for chemotherapy or surgery
  • Patients with locally unresectable primary tumours
  • Patients with symptoms from primary colorectal tumour necessitating resection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

Höglandssjukhuset

Eksjö, SE 57581, Sweden

Location

Department of Surgery

Gävle - Hudiksvall, Sweden

Location

Länssjukhuset Ryhov

Jönköping, SE 55185, Sweden

Location

Länssjukhuset

Kalmar, SE 39185, Sweden

Location

Universitetssjukhuset

Linköping, SE 58185, Sweden

Location

Vrinnevisjukhuset

Norrköping, SE 601 82, Sweden

Location

Karolinska Universitetssjukhuset

Stockholm, SE 17176, Sweden

Location

Akademiska sjukhuset

Uppsala, SE 75185, Sweden

Location

Värnamo sjukhus

Värnamo, SE 33185, Sweden

Location

Centrallasarettet

Västerås, SE 72189, Sweden

Location

Related Publications (4)

  • Mentha G, Majno PE, Andres A, Rubbia-Brandt L, Morel P, Roth AD. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg. 2006 Jul;93(7):872-8. doi: 10.1002/bjs.5346.

    PMID: 16671066BACKGROUND
  • Scoggins CR, Meszoely IM, Blanke CD, Beauchamp RD, Leach SD. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol. 1999 Oct-Nov;6(7):651-7. doi: 10.1007/s10434-999-0651-x.

    PMID: 10560850BACKGROUND
  • Benoist S, Pautrat K, Mitry E, Rougier P, Penna C, Nordlinger B. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg. 2005 Sep;92(9):1155-60. doi: 10.1002/bjs.5060.

    PMID: 16035135BACKGROUND
  • Scheer MG, Sloots CE, van der Wilt GJ, Ruers TJ. Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. Ann Oncol. 2008 Nov;19(11):1829-35. doi: 10.1093/annonc/mdn398. Epub 2008 Jul 28.

    PMID: 18662955BACKGROUND

MeSH Terms

Conditions

Colorectal NeoplasmsNeoplasm Metastasis

Interventions

Drug TherapySurgical Procedures, Operative

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesNeoplastic ProcessesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Gunnar Arbman, MD, PhD

    Department of Surgery in Östergötland

    PRINCIPAL INVESTIGATOR
  • Per Sandström, MD, PhD

    Department of Surgery in Östergötland

    STUDY CHAIR
  • Hans Starkhammar, MD, PhD

    Regional Oncologic Center, Linköping

    STUDY CHAIR
  • Bengt Glimelius, Professor

    University of Uppsala, The Karolinska University Hospital, Stockholm

    STUDY CHAIR
  • Lars Lundell, Professor

    The Karolinska University Hospital, Stockholm

    STUDY CHAIR
  • Per-Olof Nyström, Professor

    The Karolinska Universtiy Hospital, Stockholm

    STUDY CHAIR
  • Ulf Gunnarsson, Professor

    The Karolinska University hospital, Stockholm

    STUDY CHAIR
  • Lars Påhlman, Professor

    Uppsala University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant surgeon

Study Record Dates

First Submitted

January 25, 2010

First Posted

January 26, 2010

Study Start

January 1, 2010

Primary Completion

May 1, 2012

Study Completion

May 1, 2012

Last Updated

May 31, 2012

Record last verified: 2012-05

Locations